A new study found that patients with type 2 diabetes treated with GLP-1 receptor agonists and sodium-glucose cotransporter-2 ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.

How is artificial intelligence shaking up the pharma marketing space? Ted Sweetser: The first top level one that everyone is ...

Hanadie Yousef, PhD, co-founder and CEO of Juvena Therapeutics, discusses getting JUV-161 into Phase I trials this year.

While the company is well-recognized domestically, Korea’s biotech industry as a whole has historically faced challenges in gaining global recognition. Despite producing groundbreaking science, Korean ...